David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$708M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$614M |
| 3 |
Merck
MRK
|
+$521M |
| 4 |
Bank of America
BAC
|
+$492M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$646M |
| 2 |
Tesla
TSLA
|
+$607M |
| 3 |
Microsoft
MSFT
|
+$491M |
| 4 |
Accenture
ACN
|
+$482M |
| 5 |
Broadcom
AVGO
|
+$438M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 42.81% |
| 2 | Technology | 14.84% |
| 3 | Consumer Discretionary | 9.28% |
| 4 | Healthcare | 6.84% |
| 5 | Financials | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Ingles Markets
IMKTA
$1.57B
| $2M | ﹤0.01% |
26,786
+2,208
| +9% | +$162K |
|
2577
PUT
Erie Indemnity
ERIE
$13.6B
| $2M | ﹤0.01% |
+3,700
| New | +$1.68M |
|
|
DAWN
2578
DELISTED
Day One Biopharmaceuticals
DAWN
| $1.99M | ﹤0.01% |
143,135
-81,205
| -36% | -$1.16M |
|
|
SFIX
2579
Stitch Fix
SFIX
$411M
| $1.99M | ﹤0.01% |
704,824
-601,305
| -46% | -$2.34M |
|
|
VSTO
2580
DELISTED
Vista Outdoor Inc.
VSTO
| $1.98M | ﹤0.01% |
50,551
-7,982
| -14% | -$309K |
|
2581
BlueLinx
BXC
$637M
| $1.97M | ﹤0.01% |
18,713
+1,157
| +7% | +$118K |
|
2582
Gentex
GNTX
$4.89B
| $1.97M | ﹤0.01% |
+66,360
| New | +$2.06M |
|
2583
PUT
ArcelorMittal
MT
$56.1B
| $1.97M | ﹤0.01% |
+75,000
| New | +$1.72M |
|
2584
PUT
Noble Corp
NE
$7.31B
| $1.97M | ﹤0.01% |
+54,400
| New | +$2.19M |
|
2585
CALL
Lumentum
LITE
$83.1B
| $1.96M | ﹤0.01% |
31,000
| – | – |
|
2586
Johnson Controls International
JCI
$86.3B
| $1.96M | ﹤0.01% |
25,261
-131,209
| -84% | -$9.21M |
|
2587
B&G Foods
BGS
$284M
| $1.96M | ﹤0.01% |
220,719
+123,041
| +126% | +$1.04M |
|
|
KE
2588
Kimball Electronics
KE
$577M
| $1.96M | ﹤0.01% |
105,859
-4,157
| -4% | -$83.2K |
|
2589
CALL
Kinder Morgan
KMI
$70.4B
| $1.96M | ﹤0.01% |
88,600
-26,800
| -23% | -$565K |
|
2590
Sempra
SRE
$55.3B
| $1.95M | ﹤0.01% |
23,367
-41,606
| -64% | -$3.33M |
|
2591
International Flavors & Fragrances
IFF
$22.2B
| $1.95M | ﹤0.01% |
18,623
+12,165
| +188% | +$1.21M |
|
2592
Invesco
IVZ
$14.8B
| $1.95M | ﹤0.01% |
111,187
-524,504
| -83% | -$8.61M |
|
2593
PAR Technology
PAR
$806M
| $1.94M | ﹤0.01% |
+37,197
| New | +$1.93M |
|
2594
PUT
Apollo Global Management
APO
$79.5B
| $1.94M | ﹤0.01% |
+15,500
| New | +$1.79M |
|
2595
ImmunityBio
IBRX
$9.18B
| $1.93M | ﹤0.01% |
+520,053
| New | +$2.41M |
|
2596
CALL
ODDITY Tech
ODD
$675M
| $1.93M | ﹤0.01% |
+47,900
| New | +$1.85M |
|
|
MRSN
2597
DELISTED
Mersana Therapeutics
MRSN
| $1.93M | ﹤0.01% |
40,898
-17,725
| -30% | -$782K |
|
2598
CALL
Scorpio Tankers
STNG
$3.88B
| $1.93M | ﹤0.01% |
27,100
+7,700
| +40% | +$562K |
|
2599
Establishment Labs
ESTA
$2.13B
| $1.93M | ﹤0.01% |
+44,648
| New | +$1.94M |
|
2600
CTS Corp
CTS
$1.64B
| $1.93M | ﹤0.01% |
39,915
-100
| -0.2% | -$4.85K |
|
Similar funds
David Shaw's Q3 2024 Portfolio in Review
As of Q3 2024, David Shaw held 5,052 positions worth $116B, up 8.9% from $107B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw withdrew a net $4.02B in Q3 2024, closing 558 positions and reducing 1,742 holdings. Its most notable exit was WestRock Company, an estimated $148M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 40% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $115M.
- David Shaw's largest Q3 2024 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,429,800 shares worth $115M.
- David Shaw added most to NVIDIA in Q3 2024, an estimated $708M increase.
- David Shaw's biggest Q3 2024 reduction was Adobe, cutting an estimated $646M.
- David Shaw fully exited WestRock Company in Q3 2024, selling an estimated $148M.
- David Shaw's ten largest holdings make up 9.6% of its $116B portfolio in Q3 2024.
- David Shaw opened 599 new positions and closed 558 in Q3 2024.
- David Shaw's portfolio value rose 8.9% quarter-over-quarter to $116B.
Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.